NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Jun 15, 2026, 4:00 PM EDT
1.600
+0.130 (8.84%)
Pre-market: Jun 16, 2026, 7:51 AM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $170 million as of June 16, 2026. Its market cap has increased by 58.92% in one year.
Market Cap
170.00M
Enterprise Value
-37.77M
1-Year Change
58.92%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $170.00M, an increase of 23.15%. That is a compound annual growth rate of 3.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 170.00M | -62.95% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 177.67M |
| Galectin Therapeutics | 175.84M |
| Milestone Pharmaceuticals | 172.78M |
| Acumen Pharmaceuticals | 171.18M |
| AN2 Therapeutics | 170.62M |
| Alector | 169.87M |
| Innate Pharma | 169.69M |
| OnKure Therapeutics | 169.66M |